|
|
Name: |
VIKING GLOBAL INVESTORS LP |
City: |
NEW YORK |
State: |
NY |
Zip: |
10017 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
16 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
BBIO |
Bridgebio Pharma, Inc. |
7 |
- |
$28.95 |
$1,014,134,000 |
25,120,991 |
3.72% |
351,693,000 |
0 |
15.771 |
N/A |
|
RYZB |
Rayzebio, Inc. |
25 |
- |
$62.49 |
$412,977,000 |
6,642,700 |
1.51% |
265,509,000 |
0 |
10.927 |
N/A |
|
INBX |
Inhibrx, Inc. |
34 |
- |
$0.00 |
$271,731,000 |
7,150,826 |
1% |
140,513,000 |
0 |
18.963 |
N/A |
|
DNA |
Ginkgo Bioworks Holdings, Inc |
38 |
- |
$0.86 |
$241,814,000 |
143,085,126 |
0.89% |
-17,170,000 |
0 |
10.758 |
N/A |
|
ADPT |
Adaptive Biotechnologies Corp |
43 |
- |
$3.96 |
$146,969,000 |
29,993,708 |
0.54% |
-16,497,000 |
0 |
21.93 |
N/A |
|
FDMT |
4d Molecular Therapeutics Inc. |
56 |
- |
$0.00 |
$97,003,000 |
4,787,914 |
0.36% |
36,053,000 |
0 |
14.782 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
59 |
- |
$0.00 |
$89,634,000 |
8,024,565 |
0.33% |
15,407,000 |
0 |
9.839 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
64 |
- |
$0.00 |
$67,381,000 |
6,159,146 |
0.25% |
32,089,000 |
0 |
8.823 |
N/A |
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
68 |
- |
$0.00 |
$43,609,000 |
2,962,555 |
0.16% |
-10,635,000 |
0 |
5.12 |
N/A |
|
DAWN |
Day One Biopharmaceuticals,... |
70 |
- |
$0.00 |
$37,355,000 |
2,558,563 |
0.14% |
5,961,000 |
0 |
4.131 |
N/A |
|
VSTM |
Verastem, Inc. |
73 |
- |
$13.16 |
$19,994,000 |
2,456,292 |
0.07% |
24,000 |
0 |
9.736 |
Biotechnology |
|
LIAN |
Lianbio |
74 |
- |
$0.00 |
$15,932,000 |
3,564,173 |
0.06% |
10,621,000 |
0 |
3.324 |
N/A |
|
PEPG |
Pepgen Inc. |
75 |
- |
$13.99 |
$10,081,000 |
1,482,434 |
0.04% |
2,550,000 |
0 |
6.274 |
N/A |
|
RLYB |
Rallybio Corp |
76 |
- |
$0.00 |
$10,026,000 |
4,194,777 |
0.04% |
-4,110,000 |
0 |
12.152 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
77 |
- |
$0.00 |
$5,896,000 |
4,400,000 |
0.02% |
-3,696,000 |
0 |
7.343 |
N/A |
|
KNTE |
Kinnate Biopharma Inc. |
78 |
- |
$0.00 |
$4,314,000 |
1,820,462 |
0.02% |
1,765,000 |
0 |
4.165 |
N/A |
|